NCT04880720View on ClinicalTrials.gov

Deciphering a Specific Signature of the Immunosenescence Induced in COVID-19+ Patients Versus Rheumatoid Arthritis Patients

CompletedOBSERVATIONAL

Enrollment

43

Participants

Timeline

Start Date

July 19, 2021

Primary Completion Date

May 16, 2022

Study Completion Date

November 16, 2022

Conditions

SARS-Cov-2 InfectionRheumatoid Arthritis

Interventions

OTHER

Blood sampling

Blood sampling - 10mL

Trial Locations (1)

34080

CHU Montpellier, Montpellier

All Listed Sponsors

lead

University Hospital, Montpellier

OTHER